The Freshfields Podcast cover art

All Episodes

The Freshfields Podcast — 117 episodes

#
Title
1

Well-Caffeinated: What the Retail Moment Means for Private Capital

2

Essential Antitrust #51: Inside the new EU Merger Guidelines with Daniele Calisti: policy, economics and practice

3

Essential Antitrust - The Italian Voice #1: Il posto fisso (obbligato)

4

Global Shareholder Activism Insights #1: The Rise of the First-Time Activist

5

Essential Antitrust #50: New safe harbours, sharper teeth - the EU's new merger playbook

6

No Worse Off #22: Welcome to Hot Topics: charting global restructuring, one jurisdiction at a time

7

Introducing the AI Drop

8

Well-Caffeinated: Private Capital at the AI Inflection Point: What to Look for in 2026 and Beyond

9

No Worse Off #21: Asset-Backed Finance under stress

10

ESG trends to watch in 2026: Part 2: How AI, climate transition planning, supply chains and environmental rules are evolving

11

ESG trends to watch in 2026: Part 1: ESG litigation risk in a fragmented regulatory world

12

Essential Antitrust #49: Clarity in Antitrust: inside the 10 key themes shaping 2026

13

Essential Antitrust #48: Antitrust meets AI: How regulators approach AI-driven pricing and predictive analytics

14

Well-Caffeinated: What’s Past is Prologue — Assessing the Changed Legal Landscape from Year 1 of the Second Trump Administration and Looking Ahead at What Year 2 May Bring

15

No Worse Off #20: 2025 in Review

16

No Worse Off #19: Restructuring “à la francaise”

17

Tax Matters: Autumn Budget 2025 – a stealthy smorgasbord?

18

No Worse Off #18: Innovative Capital Solutions Tools in the Italian Market

19

Human-Centered Innovation – A conversation with Stephanie Toney, CBO at Diatiro Health

20

Well-Caffeinated: Private Capital Goes Retail: the Global Push to Democratize Access to Private Capital Investments

21

No Worse Off #17: Distressed disposals and LMEs – Hunkemöller and Selecta

22

The Arbitration Act 2025 is now in force. What are the key things you need to know?

23

No Worse Off #16: Petrofac in the Court of Appeal

24

Reward(ing) Half Hour - Episode 5 Navigating Employment Claims: Share Plans, Bonuses and Beyond

25

No Worse Off #15: UK restructuring plan turns five

26

Eureka: Fresh Takes on Capital Markets with Freshfields Episode #4: Midseason Proxy Review

27

Eureka: Fresh Takes on Capital Markets from Freshfields Episode #3: What to expect from SEC Enforcement

28

Tax matters: Trump 2.0 - the intersection of US tax and trade policy

29

Looking Forward: How AI is Transforming Healthcare and MedTech

30

Essential Antitrust #47: Chat with EC’s Daniele Calisti: More room for procompetitive efficiencies?

31

'EUnpacked' Episode #4: The EU’s first Omnibus - simplification or deregulation?

32

No Worse Off #14: Managing consumer redress liabilities: recent restructuring experience and the motor finance sector

33

Securing the Digital Future #4: A Conversation with Athina Tsitsou and June Lowry

34

Eureka: Fresh Takes on Capital Markets with Freshfields Episode #2: IPOs and other Routes to Capital and Liquidity: “The Garden of Forking Paths”

35

Eureka: Fresh Takes on Capital Markets from Freshfields: Episode #1: Disclosure and Governance During a Trade War

36

Ethan Klingsberg Explores the Global Secondaries Trend with Ivet Bell

37

Essential Antitrust #46: UK’s DMCCA consumer protection reforms: Key changes and how to prepare

38

No Worse Off #13: Spotlight on the Middle East

39

Well-Caffeinated: Playing the Long Game: A Conversation with Val Jacob

40

Securing the Digital Future #3: Balancing Act: Regulatory Approaches to Privacy in Content Moderation

41

No Worse Off #12: Meet Paul, Mark and Nick: our new London private credit and capital solutions trio

42

Managing Risk in Asia #10: Powering the change in Asia’s energy transition

43

Securing the Digital Future #2: Navigating the UK’s Approach to Online Safety

44

MedTech - Innovation & Inclusion: How Nada Hanafi advocates for diversity in MedTech

45

No Worse Off #11: International sanctions

46

Essential Antitrust #45: Antitrust agency leadership: stepping onto a new stage

47

Essential Antitrust #44: Redefining the role of antitrust in 2025: our Ten Key Themes forecast

48

Securing the Digital Future #1: Insights on online safety in the US

49

Life Sciences x Technology – A conversation with Derek Underwood

50

No Worse Off #10: 12 Headlines from 2024

51

Reward(ing) Half Hour: Episode 4 Applying Malus and Clawback in practice

52

Essential Antitrust #43: EU welcomes Teresa Ribera as new Competition Commissioner: business impact

53

Well-Caffeinated: What’s Brewing for the 2025 Funds Regulatory Environment?

54

No Worse Off #9: Managing Litigation Risk in Restructurings

55

Tax Matters: Autumn Budget 2024 – Delivering difficult decisions

56

Essential Antitrust #42: HSR rules changes: how to successfully navigate the new US merger control filing

57

No Worse Off #8: LMEs in England

58

Episode #3: EU elections - What you need to know about the von der Leyen II Commission

59

Out of the shadows: The growing regulatory spotlight on private capital

60

No Worse Off #7: Women in Restructuring

61

No Worse Off #6: Liability management

62

Essential Antitrust #41: Vertical restraints enforcement: trends to watch

63

Navigating Cybersecurity Risks in the Healthcare Sector

64

Episode #2: EU elections - A business outlook

65

No Worse Off #5: Cross-border restructurings

66

Essential Antitrust #40: America’s impending outbound investment controls: what investors need to know

67

Managing Risk in Asia #9: Southeast Asia – time to shine?

68

Reward(ing) Half Hour: Episode 3 Next Stop: CSOP

69

Reward(ing) Half Hour: Episode 2 Remuneration vs Compensation – the Transatlantic Pay Debate

70

No Worse Off #4: Richard Tett, 30 years in restructuring

71

Essential Antitrust #39: UK in-depth merger reviews: new process adopted by the CMA

72

No Worse Off #3: UK Restructuring Plans – Relevant Alternative, timetabling and jurisdiction

73

No Worse Off #2: After the battles, a coming of age for the UK restructuring plan?

74

Reward(ing) Half Hour: Being prepared for the (not so) unexpected: planning for executive exits

75

Tax Matters: Spring Budget 2024 – The Hunt for Blue October

76

No Worse Off #1: Overview of current restructuring trends

77

Essential Antitrust #38: What businesses can expect from China’s revised merger control regime

78

Impressions from the J.P. Morgan Healthcare Conference – A MedTech Perspective

79

Essential Antitrust #37: Antitrust in 2024: competition enforcement takes center stage

80

Legends of Tech #1: Turing with Vint and Whit: Boris Feldman in conversation with Vinton G. Cerf and Whitfield Diffie

81

Essential Antitrust Asia #9: updates with ABNR on antitrust in Indonesia

82

Managing Risk in Asia #8: Opportunities for Asian and US investors post-US Executive Order on outbound investments

83

Tax Matters: Trends in tax disputes – what should businesses be aware of?

84

Essential Antitrust #36: The UK’s Digital Markets, Competition and Consumers Bill – what you need to know

85

Essential Antitrust #35: Gender Inclusive Antitrust Toolkit: a new lens for policy and enforcement

86

Tax Matters: Autumn Statement 2023 – tax cuts in the NIC of time?

87

How secondaries have become primary to GPs and LPs

88

From chaos to control: making the case for legal project managers

89

Essential Antitrust #34: Olivier Guersent on competition enforcement: current trends

90

Essential Antitrust #33: Antitrust insights in Asia: navigating complex regulations and investment challenges

91

MedTech Across Borders – Recent Developments in Japan and the US

92

MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more

93

Essential Antitrust #32: New US HSR Rules and Merger Guidelines: key takeaways

94

Managing risk in Asia #7: Managing licensing and collaboration risks in the life sciences arena in Asia

95

Essential Antitrust #31: Recent developments in antitrust, data and IP – generative AI and MedTech

96

Essential Antitrust #30: ASSA ABLOY/Spectrum Brands: a breakthrough for M&A remedies in the US?

97

Essential Antitrust #29: Microsoft/Activision: parallel reviews in high-innovation digital deals

98

Global Perspectives on Health Data Offerings and Considerations for Innovators

99

Essential Antitrust #28: Collusion or collaboration: competition and the fight for net zero

100

Essential Antitrust #27: Some Key Takeaways from the Enforcers Roundtable at the 2023 ABA Antitrust Spring Meeting

101

MedTech Diversity and Inclusion – A Conversation with Jhaymee Tynan

102

Episode #1: The EU’s Corporate Sustainability Due Diligence Directive– a turning point for business

103

Essential Antitrust Asia #8: Hot topics in China antitrust

104

Tax Matters: Ready, Steady, Growth – Business tax implications of the UK Spring Budget 2023

105

Essential Antitrust #26: Foreign subsidy control: EU gears up to review deals and business conduct

106

Essential Antitrust #25: Antitrust in 2023: 10 key themes - growing unpredictability and brand new enforcement tools

107

MedTech - A Conversation with Stacy Hostetler

108

Essential Antitrust #24: Cartel enforcement is back: dawn raids in Europe and new targets in the US

109

MedTech - A Conversation with Gloria Seibert

110

Tax Matters podcast: How will the UK Autumn Statement 2022 affect your business?

111

Essential Antitrust #23: Merger challenges in US courts: deciphering US antitrust agencies’ recent string of defeats

112

Great (stakeholder) expectations: Episode 4 - Activists all around

113

Great (stakeholder) expectations: Episode 3 - A bastion of support for social issues

114

Great (stakeholder) expectations: Episode 2 - Unpacking the status of climate disclosures

115

State of play on Pillar Two

116

Great (stakeholder) expectations: Episode 1 - A turning point for ESG

117

Essential Antitrust Asia #7: Key antitrust issues in Japan